TRIM33 and nonpapillary renal cell carcinoma: Research into clear cell renal cell carcinoma (ccRCC) showed that TRIM33 is upregulated by treatment with an inhibitor named miR-629, which notably suppresses TGFβ-induced Smad activation as well as facilitating metastasis of ccRCC [36].